Sales and Marketing

Showing 15 posts of 11472 posts found.

Adcendo ApS to Present Data on the Expression of the Novel ADC target uPARAP in Soft Tissue and Bone Sarcoma at the 2023 American Association for Cancer Research (AACR) Annual Meeting

April 13, 2023 Sales and Marketing

Copenhagen, Denmark, 13 April, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) …

Alentis Therapeutics closes $105m Series C funding for new treatment options

April 13, 2023 Sales and Marketing

Alentis Therapeutics has announced $105m in Series C funding which was led by Jeito Capital together with Novo Holdings A/S …
christina-victoria-craft-whsnkiwwpec-unsplash_4

ImaginAb signs new license and supply agreement with Leucid Bio for CD8 ImmunoPET technology

April 12, 2023 Sales and Marketing

Biotechnology company ImaginAb has announced that it has signed a new non-exclusive License and Supply Agreement (LSA) with Leucid Bio. …

Théa Open Innovation and Galimedix announce partnership for development and commercialisation of GAL-101

April 3, 2023 Sales and Marketing

Théa Open Innovation (TOI) and Galimedix have announced that they have signed a licensing agreement granting TOI exclusive rights for …

Alzheimer’s drug Leqembi expected to generate $12.9bn in sales by 2028

March 30, 2023 Sales and Marketing

After receiving FDA approval in January 2023, Biogen/Eisai’s new Alzheimer’s disease Leqembi is expected to become a blockbuster, with a …

PureTech Health and Royalty Pharma enter KarXT royalty agreement up to $500m

March 23, 2023 Sales and Marketing

Royalty Pharma have acquired a $500m interest in PureTech’s royalty in Karuna Therapeutics’ KarXT, with $100m cash up front and …

BioNTech and OncoC4 to partner for development and commercialisation of novel checkpoint antibody

March 21, 2023 Sales and Marketing

BioNTech and OncoC4 have entered a strategic collaboration for the co-development and commercialisation of a novel checkpoint antibody for multiple …

Sun Pharma settles at $75m in industry-wide price-fixing case

March 17, 2023 Sales and Marketing

Sun Pharma has decided a settlement of $75m as part of a case surrounding various pharma companies fixing their prices. …

Sanofi to cut insulin prices by 78% starting January 2024

March 17, 2023 Sales and Marketing

French pharmaceutical company Sanofi has announced that it will cut the list price of its Lantus (insulin glargine injection) 100 …

The Association of the British Pharmaceutical Industry suspends Novo Nordisk for two years

March 16, 2023 Sales and Marketing

The Association of the British Pharmaceutical Industry (ABPI) has suspended Danish pharmaceutical company Novo Nordisk after “serious breaches” of the …

Novo Nordisk to cut insulin prices by up to 75% in 2024

March 15, 2023 Sales and Marketing

Danish pharmaceutical company Novo Nordisk has announced that it will cut its prices for insulin products by up to 75%, …

Pfizer signs $43bn deal to buy Seagen

March 14, 2023 Sales and Marketing

Pharma giant Pfizer has signed a definitive merger agreement valued at $43bn to buy biotech firm Seagen.   US-based Seagen …

Sanofi to acquire Provention Bio in $2.9bn deal

March 13, 2023 Sales and Marketing

Sanofi has agreed to acquire Provention Bio as part of a $2.9bn deal that aims to improve the company’s portfolio …

Gilead Sciences wins $175m in ongoing HIV fraud case

March 13, 2023 Sales and Marketing

Gilead Sciences, a research-based biopharmaceutical company, has won again in the lawsuit levelled against clinics, prescribers, medical labs and pharmacies …

FDA makes unusual ‘misinformation’ comment on Lucira’s EUA for COVID-19 and flu test

March 10, 2023 Sales and Marketing

The FDA has made a rare comment about what happened at Lucira Health’s Emergency Use Authorization (EUA) filing for its …

Latest content